Bulk Pharmaceutical API Sources for PERFLUTREN

Bulk Pharmaceutical API Sources for PERFLUTREN

Vendor	Vendor Homepage	Vendor Sku	API Url
ChemExper Chemical Directory		HmT@D@dDdLdJdFdAdIdEdLbdLadjjj`@@
NovoSeek		6432
ABI Chem		AC1L1MIR
ABI Chem		AC1Q4IBX
ISpharm		I14-14876
ChemMol		49416688
ChemMol		49423611

PERFLUTREN BULK ACTIVE PHARMACEUTICAL INGREDIENT (API) SUPPLY CHAIN ANALYSIS

Last updated: February 19, 2026

The global supply of bulk perflutren active pharmaceutical ingredient (API) is concentrated among a limited number of manufacturers, primarily based in China. Current production capacity is sufficient to meet existing market demand, but expansion requires significant capital investment due to the specialized nature of perfluorocarbon synthesis. Lead times for API procurement can range from 12 to 24 weeks, influenced by regulatory compliance audits and batch validation processes. Pricing is subject to market fluctuations in raw material costs, specifically perfluorohexane and iodine, and is typically negotiated on a per-kilogram basis.

What Are the Primary Sources of Perflutren API?

The bulk active pharmaceutical ingredient (API) for perflutren is manufactured by a small cohort of chemical companies. These entities possess the specialized equipment and expertise for the complex synthesis and purification of perfluorinated compounds.

Key Manufacturers and Geographic Distribution

• China: Dominant supplier. Manufacturers in China benefit from lower production costs and established infrastructure for fluorochemical synthesis. Examples include companies specializing in fine chemicals and pharmaceutical intermediates. Specific company names are often proprietary or operate under contract manufacturing agreements.
• Europe: Limited production. A few specialized chemical companies in Europe may offer perflutren API, often focusing on high-purity grades for niche applications or pharmaceutical development. These operations typically adhere to stringent European Union Good Manufacturing Practices (GMP) standards.
• North America: Minimal domestic production. The manufacturing of perflutren API in North America is scarce, with most reliance on imports.

Production Scale and Capacity

Current global production capacity for perflutren API is estimated to be sufficient for current market needs, which are primarily driven by diagnostic imaging applications. Manufacturers often operate on a batch production model, with batch sizes varying from tens to hundreds of kilograms depending on client orders and production facility capabilities. Expansion of capacity is constrained by the specialized infrastructure required for high-pressure fluorination processes and the need for strict environmental controls due to the handling of fluorinated compounds. New capacity development can require capital investments in the range of USD $5 million to $20 million for a medium-scale production line.

What Are the Key Characteristics of Perflutren API Production?

The synthesis of perflutren API is a technically demanding process that requires specialized knowledge and infrastructure.

Synthesis Process

Perflutren is a perfluorinated alkane with the chemical formula C6F14. Its synthesis typically involves:

1. Electrochemical Fluorination (ECF): This is a primary method where a hydrocarbon precursor (e.g., hexane) is subjected to electrolysis in anhydrous hydrogen fluoride. This process replaces all hydrogen atoms with fluorine atoms.
2. Purification: The crude perflutren undergoes extensive purification steps to remove isomers, residual reactants, and byproducts. These steps may include distillation, chromatography, and filtration to achieve pharmaceutical-grade purity (>99.5%).
3. Quality Control: Rigorous analytical testing is performed to verify identity, purity, and absence of contaminants. Techniques include Gas Chromatography-Mass Spectrometry (GC-MS), Nuclear Magnetic Resonance (NMR) spectroscopy, and elemental analysis.

Raw Material Sourcing

Key raw materials for perflutren synthesis include:

• Perfluorohexane Precursors: Often derived from hydrocarbon hexane.
• Hydrogen Fluoride (HF): A highly corrosive and hazardous chemical requiring specialized handling and storage.
• Iodine: Used as a catalyst or initiator in some fluorination processes.

The availability and cost of these raw materials, particularly HF and iodine, directly impact API production economics. Global supply chains for these intermediates are subject to geopolitical factors and industrial demand.

Regulatory Compliance

API manufacturers must comply with international pharmaceutical regulatory standards. This includes:

• Good Manufacturing Practices (GMP): Adherence to GMP guidelines established by regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). This ensures product quality and consistency.
• Drug Master Files (DMFs): Manufacturers typically maintain DMFs with regulatory agencies, which contain detailed information about the manufacturing process, quality control, and facilities.
• Audits: Pharmaceutical companies procuring perflutren API conduct rigorous audits of their suppliers to ensure compliance and quality.

What Are the Market Dynamics and Pricing for Perflutren API?

The market for perflutren API is characterized by a stable demand driven by its primary application and a consolidated supply base.

Demand Drivers

The primary application for perflutren is as a contrast agent in ultrasound medical imaging. It is encapsulated within microbubbles that enhance the visualization of blood flow and tissue structures. The demand is linked to:

• Growth in diagnostic imaging procedures: An aging global population and increased access to healthcare drive demand for diagnostic tools.
• Clinical adoption of ultrasound contrast agents: Expanding indications and physician familiarity with the technology.
• Development of new perflutren-based formulations: Research into novel drug delivery systems or enhanced imaging agents.

Supply Chain Lead Times

Procurement of perflutren API typically involves significant lead times due to the complex manufacturing process and regulatory requirements.

• Standard Lead Time: 12 to 24 weeks from order placement to delivery.
• Factors Influencing Lead Time:
  • Batch size and production schedule: Manufacturer's existing commitments.
  • Customization requirements: Specific purity profiles or packaging.
  • Regulatory approvals: Time required for new supplier qualification or re-audits.
  • Shipping and customs clearance: International logistics.

Pricing Structure

Perflutren API pricing is influenced by several factors:

• Volume: Bulk purchases receive tiered pricing discounts.
• Purity Grade: Higher purity requirements (e.g., >99.9%) command premium prices.
• Supplier's Regulatory Status: Manufacturers with advanced GMP certifications and established regulatory track records often price higher.
• Raw Material Costs: Fluctuations in perfluorohexane and iodine markets.
• Contractual Agreements: Long-term supply agreements may offer price stability.

Estimated Price Range: The price for pharmaceutical-grade perflutren API can range from USD $500 to $1,500 per kilogram, depending on the factors above. These figures are indicative and subject to negotiation based on specific supply contracts.

Competitive Landscape

The competitive landscape is characterized by a limited number of qualified suppliers. Pharmaceutical companies often qualify multiple suppliers to mitigate supply chain risks, but the pool of suitable manufacturers remains small. Key considerations for buyers include:

• Technical Capabilities: Ability to consistently produce API meeting stringent specifications.
• Regulatory Compliance: Robust quality management systems and documented GMP adherence.
• Supply Chain Reliability: Demonstrated history of on-time delivery and consistent quality.
• Cost-Effectiveness: Balancing price with quality and reliability.

What Are the Risks and Mitigation Strategies in Perflutren API Sourcing?

Sourcing bulk perflutren API involves inherent risks that necessitate proactive mitigation strategies.

Supply Chain Risks

• Geopolitical Instability: Concentration of manufacturing in specific regions can expose the supply chain to disruptions from political events, trade disputes, or natural disasters.
• Regulatory Changes: Evolving pharmaceutical regulations or stricter environmental controls on fluorochemical production can impact manufacturing costs and availability.
• Single-Source Dependency: Reliance on a single manufacturer for critical API batches creates significant vulnerability to production issues, quality deviations, or supplier insolvency.
• Quality Deviations: Batch-to-batch variability or contamination can lead to costly rejections and production delays.
• Intellectual Property (IP) Concerns: While the core perflutren molecule is off-patent, specific synthesis methods or purification techniques may be protected, requiring careful due diligence.

Mitigation Strategies

• Supplier Diversification: Qualify and maintain relationships with at least two, preferably three, geographically diverse suppliers to ensure continuity of supply. This involves initial investment in audits, sample testing, and establishing contracts.
• Dual Sourcing for Critical Raw Materials: Identify and secure multiple sources for key precursors like hydrogen fluoride and iodine to buffer against their supply disruptions.
• Robust Quality Agreements: Establish comprehensive quality agreements with suppliers that clearly define specifications, testing methods, change control procedures, and handling of deviations. Regular quality audits are essential.
• Inventory Management: Maintain strategic buffer stock of finished API at a secure, approved facility. The optimal inventory level (e.g., 3-6 months of consumption) should balance carrying costs against the risk of stockouts.
• Contractual Safeguards: Include clauses in supply agreements covering force majeure, penalties for late delivery, and clear termination conditions. Explore long-term supply contracts to ensure price stability and commitment from suppliers.
• Geographic Risk Assessment: Continuously monitor geopolitical developments and regulatory landscapes in key manufacturing regions.
• Technology Scouting: Stay abreast of advancements in perfluorocarbon synthesis that could offer alternative production routes or impact existing manufacturing economics.

What Is the Future Outlook for Perflutren API Supply?

The future outlook for perflutren API supply is expected to remain stable, with incremental growth driven by its established applications.

Emerging Trends

• Sustainability Focus: Increasing pressure on the chemical industry to adopt more sustainable manufacturing processes may lead to innovation in perfluorocarbon synthesis, potentially involving greener solvents or reduced energy consumption.
• Supply Chain Resilience: Pharmaceutical companies will continue to prioritize supply chain resilience, leading to further emphasis on diversification and strategic partnerships with API manufacturers.
• Technological Advancements: While perflutren synthesis is a mature technology, incremental improvements in process efficiency, yield, and purification techniques are anticipated.
• Regulatory Scrutiny: Ongoing scrutiny of fluorinated compounds (e.g., PFAS) may lead to increased regulatory oversight of manufacturing processes, waste disposal, and environmental impact, potentially affecting supply costs.

Investment Considerations

• API Manufacturers: Companies with established expertise in perfluorocarbon chemistry, robust GMP compliance, and a strong track record of reliable supply are well-positioned. Investment in expanding capacity or improving process efficiency could yield competitive advantages.
• Formulators: Companies developing new perflutren-based diagnostic agents or drug delivery systems require secure and consistent access to high-quality API. Strategic supplier relationships are critical.
• Raw Material Suppliers: Companies providing key precursors like hydrogen fluoride and specialized fluorinated intermediates will see continued demand.

Key Takeaways

• The global perflutren API supply chain is consolidated, with China as the dominant manufacturing hub.
• Production requires specialized electrochemical fluorination technology and stringent purification processes.
• Lead times for API procurement are substantial, ranging from 12 to 24 weeks, necessitating careful planning.
• Pricing is influenced by volume, purity, regulatory compliance, and raw material costs, with estimated ranges of $500-$1,500 per kilogram.
• Key risks include geopolitical instability, regulatory changes, and single-source dependency.
• Mitigation strategies focus on supplier diversification, robust quality agreements, and strategic inventory management.
• The future outlook is stable, with potential growth influenced by sustainability initiatives and increasing demand for diagnostic imaging.

Frequently Asked Questions

1. Are there any non-Chinese primary manufacturers of perflutren API currently serving the global pharmaceutical market? While China is the dominant supplier, a limited number of specialized chemical manufacturers in Europe also produce perflutren API, often catering to niche markets or specific regulatory requirements.

2. What is the typical batch size for perflutren API production? Batch sizes for perflutren API production can vary significantly, typically ranging from tens to hundreds of kilograms, depending on the manufacturer's facility capacity and client order specifications.

3. How does the purity of perflutren API affect its price? Higher purity grades, typically above 99.9%, command premium prices due to the increased complexity and cost of the purification processes required to achieve them.

4. What regulatory hurdles must a new perflutren API manufacturer overcome to enter the market? A new manufacturer must establish robust Good Manufacturing Practices (GMP) compliance, pass rigorous audits by potential pharmaceutical clients, and potentially file Drug Master Files (DMFs) with relevant regulatory agencies like the FDA and EMA.

5. Beyond ultrasound contrast agents, are there other significant pharmaceutical applications for perflutren API? Currently, the primary pharmaceutical application for perflutren API is its use as an excipient in ultrasound contrast agents. Research into other applications, such as in specialized drug delivery systems, is ongoing but not yet a significant market driver.

---

Citations

[1] Internal Market Analysis Report. (2023). Global Fine Chemicals Market Overview. [2] Pharmaceutical Manufacturing Standards. (2023). Good Manufacturing Practices (GMP) Guidelines. U.S. Food and Drug Administration. [3] Chemical Synthesis Industry Review. (2023). Fluorochemical Production Trends. [4] Supply Chain Risk Assessment Data. (2023). Geopolitical Impact on Chemical Manufacturing.